Antimicrobial Susceptibility Testing Market Expected to Reach $ 4,736.03 Million by 2030-Allied Market Research

According to a new report published by Allied Market Research, titled, " Antimicrobial Susceptibility Testing Market by Product Type, Method Type, End User and Region: Global Opportunity Analysis and Industry Forecast, 2021–2030," the global antimicrobial susceptibility testing market was valued at $3,040.00 million in 2020, and is estimated to reach $4,736.03 million by 2030, growing at a CAGR of 5.8% from 2021 to 2030.

Antimicrobial susceptibility testing (AST) is a widely used laboratory method by medical technologists (clinical laboratory scientists) to determine which antimicrobial regimen is most effective for specific patients. It is used to evaluate which antimicrobial prevents the growth of bacteria, fungi, and other microorganisms that cause illness. After microorganisms that cause infection, such as bacteria, fungi, and viruses, have been isolated in a culture of the specimen, susceptibility testing is performed on them. On a broader scale, it assists in the evaluation of treatment services offered by hospitals, clinics, and national infectious disease control and preventive programs.

The testing evaluates a bacterium, fungi or viral strain's sensitivity to a panel of respective antibiotics, antifungals antivirals. The microorganism is exposed to these antimicrobials, and the test determines whether or not the microorganism will grow in the presence of them. This data is provided to clinicians as the Minimum Inhibitory Concentration (MIC), which is a measure of a microorganism's sensitivity or resistance to an antimicrobial. Antimicrobial susceptibility testing is used to identify bacteria's antibiotic resistance mechanisms.

The global antimicrobial susceptibility testing market is growing due to an increase in the prevalence of infectious diseases, as well as epidemic and pandemic occurrences, Infectious disease outbreaks such as Neisseria meningitides, Shigella, Neisseria gonorrhoeae, and Salmonella serotype typhi are also increasing demand for antimicrobial susceptibility testing kits. As a result, medical practitioners have recognized the significance of performing antimicrobial susceptibility tests (ASTs), and it is now an essential component of clinical microbiology laboratories.

In addition, rapidly expanding geriatric population, which leads to an increase in chronic diseases, and rising awareness programs and initiatives for personalized treatment. Furthermore, growing use of antimicrobial susceptibility testing by pharmaceutical businesses contributes significantly to the growth of the antimicrobial susceptibility testing market. Researchers recently had to undertake continuous surveillance efforts for resistance patterns as a result of bacterial DNA changes. Thus, the aforementioned factors are anticipated to drive the growth of the antimicrobial susceptibility testing market. In addition, initiatives taken by governments, improvement in development of innovative technologies in the healthcare sector, thereby propelling the growth of the market.

The antimicrobial susceptibility testing market is segmented into product type, method type, end user, and region. On the basis of product type, the market is divided into manual products, automated products, and consumables. The manual products dominated the market in 2020, and is expected to continue this trend during the forecast period, due to increase in demand for susceptibility disks, susceptibility plates, minimum inhibitory concentration (MIC) strips due rising incidences of antibiotic resistance, new product launches in developing countries.

Depending on method type, the market is classified into ETEST, disks diffusion, rapid automation method and others. The disk diffusion segment led the market in 2020, and is expected to retain its dominance during the forecast period, owing to its ease of availability, simple for usage and low cost.

By end user, the market is bifurcated into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, and others. The hospitals & diagnostic laboratories exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of infectious diseases, emergence of new disease due to mutations, discovery of novel drugs and rise in cases of antimicrobial resistance.

North America accounted for a majority of the global antimicrobial susceptibility testing market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of antibiotic resistance, presence of key players, increase in healthcare expenditure, advancements in technology and rise in government initiatives in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to increase in overall population, and increased investments in healthcare sector in the region

Key Findings Of The Study

• By product type, the manual segment was the highest contributor to the market in 2020.
• On the basis of method type, the disk diffusion segment dominated the market in 2020
• Depending on end user, the hospitals and diagnostic laboratories exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period.
• Region wise, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.